The Skindex-mini: a streamlined QOL measurement tool suitable for routine use in clinic

http://bit.ly/2CwhIFY

Surgical Pearl: Use of surgical scrub sponge for auricular dressing

http://bit.ly/2T7G6mz

All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis

- Although psoriasis is associated with several comorbidities, mortality risk needs clarification. Psoriasis is associated with increased mortality risk from all-causes in a dose-response manner with disease severity and from several specific causes such as cardiovascular, liver, kidney, and infectious disease. Thus, psoriasis patients should receive appropriate screening and preventative interventions.

http://bit.ly/2GEdOPq

An epidermal cyst of the penis after distal hypospadias surgery: a case report

Epidermoid cyst is a benign tumor that can occur anywhere in the body but is rarely seen in the penis. Congenital and previous penile surgeries have been reported to be involved in the etiology of the disease,...

http://bit.ly/2CxUE9F

Pruritis Can Be Frequent, Severe With Cancer Immunotherapy

Immunotherapy-related pruritis can be frequent and even severe in cancer patients receiving treatment with any of the new agents
Medscape Medical News

https://wb.md/2T78FAD

Corrigendum to ‘The role of dietary sodium in autoimmune diseases: The salty truth’ [AUTREV 17-11 (2018) 1069–1073]

Publication date: Available online 23 December 2018

Source: Autoimmunity Reviews

Author(s): Kassem Sharif, Howard Amital, Yehuda Shoenfeld

http://bit.ly/2GyZCqK

The Consortium for Food Allergy Research (CoFAR) The First Generation

Publication date: Available online 23 December 2018

Source: Journal of Allergy and Clinical Immunology

Author(s): Hugh A. Sampson, M Cecilia Berin, Marshall Plaut, Scott H. Sicherer, Stacie Jones, A Wesley Burks, Robert Lindblad, Donald YM. Leung, Robert A. Wood

Abstract

The Consortium for Food Allergy Research (CoFAR) was established by the The National Institute of Allergy and Infectious Diseases (NIAID) in 2005 as a collaborative research program bringing together centers focused on the study of food allergy. The Consortium was charged with developing studies to better understand the pathogenesis and natural history of food allergy, as well as potential approaches to the treatment of food allergy. In its first iteration, an observational study of infants with milk and egg allergy was established and studies of oral immunotherapy for egg allergy and sublingual immunotherapy for peanut allergy were initiated, as was a Phase 1 study of a recombinant peanut protein vaccine. The CoFAR was renewed in 2010 for an additional 5-year period during which the initial observational study was continued, a study of eosinophilic esophagitis was initiated, and new therapeutic trials were established to study epicutaneous immunotherapy for peanut allergy and to compare the safety and efficacy of egg OIT to the ingestion of baked egg for the treatment of egg allergy. The results of these efforts will be reviewed in this Rostrum, with a brief look to the future of the Consortium.

http://bit.ly/2Sk7nlK